Kenvue Brands
As of the edition of 20 October 2026, Kenvue Brands runs 9 drugs, 9 of them marketed.
Sources: ClinicalTrials.gov, FDA Orange Book and Purple Book, other approval registers, company records.
Drugs by status
| Status | Count |
|---|---|
| Marketed | 9 |
| Total | 9 |
Marketed drugs and when their US protection ends
| Drug | US protection | Route B rows |
|---|---|---|
| Acetaminophen | none listed | 17 |
| Ibuprofen | none listed | 11 |
| Budesonide | Ends 2029 (exclusivity) | 5 |
| Famotidine | none listed | 2 |
| Cetirizine | none listed | 3 |
| Loperamide | none listed | 1 |
| Oxymetazoline | none listed | 13 |
| Pseudoephedrine | none listed | 4 |
| Minoxidil | none listed | 1 |
A route B row is one company at one target.